Tweet This

Biosimilars User Fee Act

Creates an abbreviated licensure pathway for biologic products that are demonstrated to be “biosimilar” to or “interchangeable” with an FDA-licensed biologic product. This pathway is provided in the part of the law known as the Biologics Price Competition and Innovation Act (BPCI Act).

Automatic Enrollment

Provision of the ACA requiring organizations with more than 200 full time employees to enroll all new full-time employees in a health plan.